Position in ERAS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,225,570
+$950,677 QoQ
Shares Held
75,746
+2.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtus Investment Advisers, LLC holds $81,748,894 across 171 Biotechnology names. ERAS ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,598 | $2,779,958 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
357,747 | $2,743,919 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,869 | $2,620,743 | |
| 4 | INCY |
Incyte Corp
|
27,189 | $2,559,028 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,471 | $2,471,929 | |
| 6 | MRNA |
Moderna, Inc.
|
28,656 | $1,455,724 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
383,763 | $1,347,008 | |
| 8 | ERAS |
Erasca, Inc.
This page
|
75,746 | $1,225,570 |
All Filings in ERAS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,225,570 | 75,746 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $274,893 | 73,896 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $162,128 | 74,371 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $78,052 | 61,459 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $85,516 | 62,421 | Shares | Other | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||